Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou GET Technology Development is a state-owned investment vehicle serving as the investment arm of the Guangzhou Development District (GDD). It focuses on equity investments in advanced high-tech projects, particularly in knowledge-intensive industries like R&D services, life and health science, and inspection services. A notable investment includes a 2017 joint venture with BeiGene to establish BeiGene Biologics Co., Ltd. for commercial-scale biologics manufacturing in Guangzhou.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou GET Technology Development.